Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Th1 cell modulation involves influencing the differentiation, activation, or function of T helper 1 (Th1) cells, a subset of CD4+ T lymphocytes critical for cellular immunity. Modulation can be achieved through targeting cytokines (e.g., IL-12, IFN-γ), cell surface receptors (e.g., CXCR3, IL-12R), or intracellular signaling pathways (e.g., STAT4, T-bet). The goal is to either enhance Th1 responses for defense against intracellular pathogens or suppress them to treat autoimmune diseases.
Varies depending on the specific modulator; examples include cytokine neutralization, receptor antagonism, and inhibition of intracellular signaling pathways.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T helper 1 cell modulation (Th1 modulation).